Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CyclASol in Dry Eye Disease
NCT03292809Phase 3Completed
- Sponsor
- Novaliq GmbH
- Start
- Oct 2017
- Primary completion
- May 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vevye in dry eye disease (DED), sponsored by Novaliq GmbH. Started Oct 2017; status: completed.
02
Drugs
vevye
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT03292809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03292809.